tffpharma.com - TFFP Company profit before taxes, interest and amortization
TFF Pharmaceuticals relies on third-party contractors for the synthesis of powder medications, thereby minimizing capital expenditures. The GURU.Markets platform reports the company's total operating profit, where serves as the base parameter value. The market is cautiously assessing the potential of the freeze-drying technology, maintaining a wait-and-see approach. Meanwhile, inhalation developments support environmental sustainability by reducing hazardous medical waste through the elimination of needles.
TFF Pharmaceuticals, Inc. - analytical breakdowns and key metrics (TFFP)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio TFF Pharmaceuticals|TFFP - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio TFF Pharmaceuticals Inc.|TFFP - Company Aggregate Debts|Debts to Book Capitalization Ratio TFF Pharmaceuticals|TFFP - Company Long-Term Debts|Current Liabilities TFF Pharmaceuticals|Intermediate Coverage Ratio tffpharma.com
- earnings and market ratios statistics:
TFFP - Company Net Income|Forward Earnings TFF Pharmaceuticals|TFFP - P/E Multiple|Future Price to Earnings Multiple tffpharma.com|TFFP - PEG Multiple|EV/EBITDA Multiple TFF Pharmaceuticals|TFFP - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year TFF Pharmaceuticals|TFFP - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months tffpharma.com|TFFP - Earnings growth in current year|Earnings growth forecast for next year TFF Pharmaceuticals
Summary company analytics:TFF Pharmaceuticals, Inc, TFFP
Against the backdrop of stagnation at TFF Pharmaceuticals (TFFP) and the potential sale of patents, the consolidated EBITDA with a value of reflects the actual cash flow from core operations before taxes and interest. This indicator captures the company's actual earnings, allowing investors to avoid an illusion of stability amid rising debt loads and assess the risk of a deep asset drawdown.
Who TFF Pharmaceuticals competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Galapagos - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization AMPH|PCRX: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization SPRY (ars-pharma.com)|Operating profit before deduction of amortization TBPH|AQST: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization scPharmaceuticals Inc. (SCPH)|TECX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA TNXP (Tonix Pharmaceuticals)|Income before deduction of interest, taxes and amortization SXTC|Eupraxia Pharma - Operating profit EBITDA|BHST - Operating profit EBITDA|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Oramed Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Entera Bio Ltd|Operating profit before deduction of amortization ipatherapeutics.com (HYFT)|Operating profit EBITDA ABVC|Operating profit EBITDA Cumberland Pharmaceuticals Inc (CPIX)|Operating profit EBITDA QNTM (Quantum BioPharma Limited)|FGEN - Operating profit before deduction of amortization|Telomir Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization Rani Therapeutics|SNYR (synergychc.com) - Operating profit before deduction of amortization|Rallybio (RLYB) - Operating profit EBITDA|Operating profit before deduction of amortization LEXX|PULM (Pulmatrix Corporation) - Company profit before taxes, interest and amortization|Operating profit EBITDA PTHL|Operating income before deduction of amortization aptorumgroup.com|Operating profit EBITDA LYRA (Lyra Therapeutics)|IBO - Operating profit before deduction of amortization|TNF Pharma - Operating profit EBITDA|YCBD - Operating profit EBITDA|PainReform Ltd. (PRFX) - Profit before payment of interest, taxes and amortization|CYTO (Altamira Therapeutics Ltd.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Lipella Pharmaceuticals, Inc.|OptiNose Inc (OPTN) - Operating income before deduction of amortization|Operating profit before deduction of amortization PIRS (Pieris)|Company profit before taxes, interest and amortization PROC|Operating profit EBITDA PTPI (Petros Pharmaceuticals)|QLI (qlsyy.net) - Profit before deduction of interest, taxes, depreciation and amortization|ACELYRIN - Operating profit EBITDA
